UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
x
|
QUARTERLY
REPORT UNDER SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF
1934
|
For
the quarterly period ended June 30, 2008.
o
|
TRANSITION
REPORT UNDER SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF
1934
|
For
the transition period from
to
Commission
File Number: 000-32065
HYDROGEN
CORPORATION
(Exact
name of registrant as specified in its charter)
Nevada
|
86-0965692
|
(State
or other jurisdiction of
|
(IRS
Employer Identification No.)
|
incorporation
or organization)
|
|
|
|
10
East 40
th
Street, New York, NY
|
10016-0301
|
(Address
of principal executive
offices)
|
(Zip
code)
|
(212)
672-0380
(Registrant’s
telephone number, including area code)
Indicate
by check mark whether the registrant: (1) filed all reports required to be
filed
by Section 13 or 15(d) of the Exchange Act during the preceding 12 months
(or
for such shorter period that the Registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90
days.
Yes
x
No
o
Indicate
by check mark whether the registrant a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company.
See
the definitions of “large accelerated filer,” “accelerated filer,” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
o
|
Accelerated filer
o
|
Non-Accelerated Filer
o
|
Smaller reporting company
x
|
(Do
not
check if smaller reporting company)
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Yes
o
No
x
As
of
August 18, 2008, there were 12,769,904 shares of common stock, par value
$0.001
per share, outstanding.
TABLE
OF CONTENTS
|
|
PAGE
|
PART
I.
|
FINANCIAL
INFORMATION
|
|
|
|
|
Item
1
.
|
Financial
Statements
|
|
|
|
|
|
Condensed
Consolidated Balance Sheets, June 30, 2008 (unaudited)
|
|
|
and
December 31, 2007
|
1
|
|
|
|
|
Condensed
Consolidated Statements of Operations for the three and six
month
|
|
|
periods
ended June 30, 2008 and June 30, 2007 and for the period
from
|
|
|
November
11, 2001 (“Inception”) to June 30, 2008 (unaudited)
|
2
|
|
|
|
|
Condensed
Consolidated Statements of Shareholders’ Equity (Deficiency)
from
|
|
|
Inception
through June 30, 2008
|
3
|
|
|
|
|
Condensed
Consolidated Statements of Cash Flows for the six month
periods
|
|
|
ended
June 30, 2008 and June 30, 2007 and for the period from
Inception
|
|
|
through
June 30, 2008 (unaudited)
|
4
|
|
|
|
|
Notes
to Condensed Consolidated Financial Statements (unaudited)
|
5
|
|
|
|
Item
2
.
|
Management's
Discussion and Analysis or Plan of Operation
|
14
|
|
|
|
Item
3
.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
25
|
|
|
|
Item
4
.
|
Controls
and Procedures
|
25
|
|
|
|
PART
II.
|
OTHER
INFORMATION
|
|
|
|
|
Item
1
.
|
Legal
Proceedings
|
26
|
|
|
|
Item
2
.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
26
|
|
|
|
Item
3
.
|
Defaults
Upon Senior Securities
|
26
|
|
|
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
26
|
|
|
|
Item
5
.
|
Other
Information
|
26
|
|
|
|
Item
6
.
|
Exhibits
|
26
|
|
|
|
Signatures
|
|
|
27
|
PART
I -
FINANCIAL
INFORMATION
Item
1.
Financial
Statements
This
Form
10-Q (the “Quarterly Report”) contains “forward-looking statements” regarding
future events and future results of HydroGen Corporation (the “Company”) that
are based on current expectations, estimates, forecasts, and projections
and the
beliefs and assumptions of the management of the Company and are made pursuant
to the safe harbor provisions of Section 27A of the Securities Act of 1933,
as
amended (the “Act”), and Section 21E of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”). These statements often can be identified by the
use of terms such as “may”, “will”, “expect”, “believe”, “anticipate”, “plan”,
“intend”, “project”, “estimate”, “approximate”, or “continue”, and other similar
expressions or the negative thereof. The Company wishes to caution readers
not
to place undue reliance on any such forward-looking statements, which speak
only
as of the date made. Any forward-looking statements represent management's
best
judgment as to what may occur in the future. However, forward-looking statements
are subject to risks, uncertainties and important factors beyond the control
of
the Company that could cause actual results and events to differ materially
from
historical results of operations and events and those presently anticipated
or
projected. Factors that might cause or contribute to such differences include,
but are not limited to, those discussed in the Company’s Annual Report on Form
10-KSB for the year ended December 31, 2007 under the Section entitled “Risk
Factors.” Except as required by applicable law or regulation, the Company
disclaims any obligation subsequently to revise any forward-looking statements
to reflect events or circumstances after the date of such statement or to
reflect the occurrence of anticipated or unanticipated events.
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
|
JUNE
30,
2008
|
|
DECEMBER
31,
2007
|
|
|
|
(unaudited)
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT
ASSETS
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$
|
683,905
|
|
$
|
8,065,758
|
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
25,000
|
|
|
165,628
|
|
|
|
|
|
|
|
|
|
Other
current assets
|
|
|
871,573
|
|
|
1,837,657
|
|
|
|
|
|
|
|
|
|
TOTAL
CURRENT ASSETS:
|
|
|
1,580,478
|
|
|
10,069,043
|
|
|
|
|
|
|
|
|
|
Property
and equipment, net
|
|
|
4,955,207
|
|
|
4,799,588
|
|
|
|
|
|
|
|
|
|
Other
assets
|
|
|
61,789
|
|
|
66,433
|
|
|
|
|
|
|
|
|
|
TOTAL
ASSETS
|
|
$
|
6,597,474
|
|
$
|
14,935,064
|
|
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT
LIABILITIES
|
|
|
|
|
|
|
|
Accounts
payable and accrued expenses
|
|
$
|
3,288,947
|
|
$
|
3,094,511
|
|
Capital
lease obligations, current portion
|
|
|
125,614
|
|
|
102,804
|
|
|
|
|
|
|
|
|
|
TOTAL
CURRENT LIABILITIES
|
|
|
3,414,561
|
|
|
3,197,315
|
|
|
|
|
|
|
|
|
|
LONG-TERM
LIABILITIES:
|
|
|
|
|
|
|
|
Capital
lease obligations, net of current portion
|
|
|
69,935
|
|
|
74,813
|
|
|
|
|
|
|
|
|
|
TOTAL
LIABILITIES
|
|
$
|
3,484,496
|
|
$
|
3,272,128
|
|
|
|
|
|
|
|
|
|
Commitments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS’
EQUITY:
|
|
|
|
|
|
|
|
Common
stock, par value $0.001, authorized 65,000,000
shares,
12,769,904 issued and outstanding at June 30, 2008 and December
31,
2007.
|
|
|
12,770
|
|
|
12,770
|
|
|
|
|
|
|
|
|
|
Additional
paid-in capital
|
|
|
43,825,445
|
|
|
43,180,779
|
|
|
|
|
|
|
|
|
|
Deficit
accumulated during the development stage
|
|
|
(40,725,237
|
)
|
|
(31,530,613
|
)
|
|
|
|
|
|
|
|
|
TOTAL
SHAREHOLDERS’ EQUITY
|
|
|
3,112,978
|
|
|
11,662,936
|
|
|
|
|
|
|
|
|
|
TOTAL
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
$
|
6,597,474
|
|
$
|
14,935,064
|
|
See
accompanying notes to the condensed financial statements
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
CONDENSED
CONSOLIDATED
STATEMENTS OF OPERATIONS
(unaudited)
|
|
FOR
THE THREE MONTHS
ENDED
JUNE
30,
|
|
FOR
THE SIX
MONTHS
ENDED
JUNE
30,
|
|
NOVEMBER
11,
2001
(INCEPTION)
THROUGH
|
|
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
June
30, 2008
|
|
Grant
Revenue
|
|
$
|
57,700
|
|
$
|
380,619
|
|
$
|
377,042
|
|
$
|
816,684
|
|
$
|
2,569,661
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and development expenses
|
|
|
2,599,000
|
|
|
2,929,000
|
|
|
6,151,349
|
|
|
5,219,489
|
|
|
21,165,509
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs
and expenses (including stock-based compensation expense of $285,029
and
$155,679, for the three month periods ended June 30, 2008 and June
30,
2007, and $644,666 and $275,732 for the six month periods ended
June 30,
2008 and June 30, 2007.)
|
|
|
1,854,926
|
|
|
1,774,251
|
|
|
3,882,095
|
|
|
3,330,495
|
|
|
22,824,439
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LOSS
FROM OPERATIONS
|
|
|
(4,396,226
|
)
|
|
(4,322,632
|
)
|
|
(9,656,402
|
)
|
|
(7,733,300
|
)
|
|
(41,420,287
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
and other income
|
|
|
430,451
|
|
|
234,055
|
|
|
481,904
|
|
|
503,048
|
|
|
2,537,254
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
and other financing charges
|
|
|
(12,302
|
)
|
|
(5,434
|
)
|
|
(20,126
|
)
|
|
(9,326
|
)
|
|
(818,393
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charge
for repricing conversion price of convertible debt
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(875,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET
LOSS
|
|
$
|
(3,978,077
|
)
|
$
|
(4,094,011
|
)
|
$
|
(9,194,624
|
)
|
$
|
(7,239,578
|
)
|
$
|
(40,576,426
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average common shares outstanding (basic and diluted)
|
|
|
12,769,904
|
|
|
12,769,904
|
|
|
12,769,904
|
|
|
12,769,904
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss per share (basic and diluted)
|
|
$
|
(0.31
|
)
|
$
|
(0.32
|
)
|
$
|
(0.72
|
)
|
$
|
(0.57
|
)
|
|
|
|
See
accompanying notes to the condensed financial statements
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
CONDENSED
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(DEFICIENCY)
(unaudited)
|
|
Common
Stock
|
|
Series
B Preferred Stock
|
|
Additional
Paid-in
|
|
Deficit
Accumulated During the Development
|
|
Total
Shareholders’
Equity
|
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Capital
|
|
Stage
|
|
(Deficiency)
|
|
Balance,
November 11, 2001 (Inception)
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Capital
contributed on November 11, 2001
|
|
|
-
|
|
|
-
|
|
|
377,704
|
|
$
|
378
|
|
$
|
476
|
|
$
|
-
|
|
$
|
854
|
|
Net
loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(5,564
|
)
|
|
(5,564
|
)
|
Balance,
December 31, 2001
|
|
|
-
|
|
$
|
-
|
|
|
377,704
|
|
$
|
378
|
|
$
|
476
|
|
$
|
(5,564
|
)
|
$
|
(4,710
|
)
|
Net
loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(104,354
|
)
|
|
(104,354
|
)
|
Balance,
December 31, 2002
|
|
|
-
|
|
$
|
-
|
|
|
377,704
|
|
$
|
378
|
|
$
|
476
|
|
$
|
(109,918
|
)
|
$
|
(109,064
|
)
|
Net
loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(163,128
|
)
|
|
(163,128
|
)
|
Balance,
December 31, 2003
|
|
|
-
|
|
$
|
-
|
|
|
377,704
|
|
$
|
378
|
|
$
|
476
|
|
$
|
(273,046
|
)
|
$
|
(272,192
|
)
|
Equity
issued for compensation in January and June, at $22.81 per preferred
share
|
|
|
-
|
|
|
-
|
|
|
28,012
|
|
|
28
|
|
|
638,802
|
|
|
-
|
|
|
638,830
|
|
Issuance
of equity in connection with issuance of convertible notes from
November
24 - December 20, at $16.36 per preferred share
|
|
|
-
|
|
|
-
|
|
|
27,850
|
|
|
28
|
|
|
455,480
|
|
|
-
|
|
|
455,508
|
|
Net
loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(1,734,654
|
)
|
|
(1,734,654
|
)
|
Balance,
December 31, 2004
|
|
|
-
|
|
$
|
-
|
|
|
433,566
|
|
$
|
434
|
|
$
|
1,094,758
|
|
$
|
(2,007,700
|
)
|
$
|
(912,508
|
)
|
Vesting
of equity issued for compensation in January and June, 2004 at
$22.81 per
preferred share
|
|
|
-
|
|
|
-
|
|
|
21,731
|
|
|
22
|
|
|
513,319
|
|
|
-
|
|
|
513,341
|
|
Equity
issued on March 8 to existing shareholders electing antidilution
protection, at $23.18 per preferred share
|
|
|
-
|
|
|
-
|
|
|
4,862
|
|
|
5
|
|
|
112,674
|
|
|
-
|
|
|
112,679
|
|
Issuance
of equity in connection with issuance of convertible notes from
January 4
- February 23, at $16.82 per preferred share
|
|
|
-
|
|
|
-
|
|
|
6,147
|
|
|
6
|
|
|
103,397
|
|
|
-
|
|
|
103,403
|
|
Conversion
of convertible notes on July 7, 2005
|
|
|
-
|
|
|
-
|
|
|
60,446
|
|
|
60
|
|
|
1,999,940
|
|
|
-
|
|
|
2,000,000
|
|
Repricing
of convertible notes
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
875,000
|
|
|
-
|
|
|
875,000
|
|
Forgiveness
of debt by significant shareholder on July 7, 2005
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
150,000
|
|
|
-
|
|
|
150,000
|
|
Chiste
shareholders’ interest on July 7, 2005, post-reverse
merger
|
|
|
375,865
|
|
|
376
|
|
|
-
|
|
|
-
|
|
|
(376
|
)
|
|
-
|
|
|
-
|
|
Sale
of equity securities on July 7, 2005 at $31.70 per preferred
share
|
|
|
-
|
|
|
-
|
|
|
427,072
|
|
|
427
|
|
|
12,394,137
|
|
|
-
|
|
|
12,394,564
|
|
Conversion
of preferred securities into common stock on August 29, 2005, valued
at
$4.46 per common share
|
|
|
7,071,735
|
|
|
7,072
|
|
|
(953,824
|
)
|
|
(954
|
)
|
|
(6,118
|
)
|
|
-
|
|
|
-
|
|
Dividend
- round up of odd-lot shareholders on August 29, September 14 and
November 1, valued at $4.53 per share
|
|
|
32,865
|
|
|
33
|
|
|
-
|
|
|
-
|
|
|
148,778
|
|
|
(148,811
|
)
|
|
-
|
|
Sale
of common shares on September 29, 2005 for $4.46 per share
|
|
|
134,439
|
|
|
134
|
|
|
-
|
|
|
-
|
|
|
584,746
|
|
|
-
|
|
|
584,880
|
|
Net
loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(5,741,197
|
)
|
|
(5,741,197
|
)
|
Balance,
December 31, 2005
|
|
|
7,614,904
|
|
$
|
7,615
|
|
|
-
|
|
$
|
-
|
|
$
|
17,970,255
|
|
$
|
(7,897,708
|
)
|
$
|
10,080,162
|
|
Sale
of common shares on May 2, 2006 for $5.00 per share
|
|
|
5,155,000
|
|
|
5,155
|
|
|
-
|
|
|
-
|
|
|
24,064,229
|
|
|
-
|
|
|
24,069,384
|
|
Net
loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(7,423,300
|
)
|
|
(7,423,300
|
)
|
Stock
based compensation
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
561,331
|
|
|
-
|
|
|
561,331
|
|
Balance,
December 31, 2006
|
|
|
12,769,904
|
|
$
|
12,770
|
|
|
-
|
|
$
|
-
|
|
$
|
42,595,815
|
|
$
|
(15,321,008
|
)
|
$
|
27,287,577
|
|
Net
loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(16,209,605
|
)
|
|
(16,209,605
|
)
|
Stock
based compensation
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
584,964
|
|
|
-
|
|
|
584,964
|
|
Balance,
December 31, 2007
|
|
|
12,769,904
|
|
$
|
12,770
|
|
|
-
|
|
$
|
-
|
|
$
|
43,180,779
|
|
$
|
(31,530,613
|
)
|
$
|
11,662,936
|
|
Net
loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(9,194,624
|
)
|
|
(9,194,624
|
)
|
Stock
based compensation
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
644,666
|
|
|
-
|
|
|
644,666
|
|
Balance,
June 30, 2008
|
|
|
12,769,904
|
|
$
|
12,770
|
|
|
-
|
|
$
|
-
|
|
$
|
43,825,445
|
|
$
|
(40,725,237
|
)
|
$
|
3,112,978
|
|
See
accompanying notes to the condensed financial statements
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
|
|
FOR
THE SIX MONTHS ENDED
JUNE
30,
|
|
NOVEMBER
11,
2001
(INCEPTION)
THROUGH
JUNE 30,
|
|
|
|
2008
|
|
2007
|
|
2008
|
|
CASH
FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(9,194,624
|
)
|
$
|
(7,239,578
|
)
|
$
|
(40,576,426
|
)
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
396,153
|
|
|
293,340
|
|
|
1,267,295
|
|
Amortization
of discount on convertible notes
|
|
|
-
|
|
|
-
|
|
|
558,911
|
|
Stock-based
compensation
|
|
|
644,666
|
|
|
275,732
|
|
|
3,055,811
|
|
Financing
cost recognized upon change in terms of convertible debt
|
|
|
-
|
|
|
-
|
|
|
875,000
|
|
Loss
on disposal of property and equipment
|
|
|
-
|
|
|
-
|
|
|
35,416
|
|
Changes
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
Decrease
(Increase) in accounts receivable
|
|
|
140,628
|
|
|
(118,211
|
)
|
|
(25,000
|
)
|
Decrease
(Increase) in other current assets
|
|
|
966,084
|
|
|
(446,088
|
)
|
|
(871,573
|
)
|
Decrease
(Increase) in other assets
|
|
|
4,644
|
|
|
(9,416
|
)
|
|
(61,789
|
)
|
Increase
in accounts payable and accrued expenses
|
|
|
194,436
|
|
|
263,805
|
|
|
3,288,947
|
|
NET
CASH USED IN OPERATING ACTIVITIES
|
|
$
|
(6,848,013
|
)
|
$
|
(6,980,416
|
)
|
$
|
(32,453,408
|
)
|
|
|
|
|
|
|
|
|
|
|
|
CASH
FLOW FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
Purchase
of short-term investments
|
|
|
-
|
|
|
(6,007,442
|
)
|
|
(37,195,809
|
)
|
Maturity
of short-term investments
|
|
|
-
|
|
|
5,725,000
|
|
|
37,195,809
|
|
Purchase
of property and equipment
|
|
|
(441,897
|
)
|
|
(978,768
|
)
|
|
(5,847,229
|
)
|
NET
CASH USED IN INVESTING ACTIVITIES
|
|
$
|
(441,897
|
)
|
$
|
(1,261,210
|
)
|
$
|
(5,847,229
|
)
|
|
|
|
|
|
|
|
|
|
|
|
CASH
FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common stock for cash, net of expenses, including the exchange
of
member’s units and preferred stock
|
|
|
-
|
|
|
-
|
|
|
37,049,682
|
|
Proceeds
from notes payable, related parties
|
|
|
-
|
|
|
-
|
|
|
150,000
|
|
Principal
payments on capital lease obligations
|
|
|
(91,943
|
)
|
|
(39,350
|
)
|
|
(215,140
|
)
|
Proceeds
from issuance of convertible notes payable including amount allocated
to
equity component
|
|
|
-
|
|
|
-
|
|
|
2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
NET
CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES
|
|
$
|
(91,943
|
)
|
$
|
(39,350
|
)
|
$
|
38,984,542
|
|
|
|
|
|
|
|
|
|
|
|
|
NET
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
|
|
|
(7,381,853
|
)
|
|
(8,280,976
|
)
|
|
683,905
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH
AND CASH EQUIVALENTS, beginning of period
|
|
|
8,065,758
|
|
|
14,170,530
|
|
|
-
|
|
CASH
AND CASH EQUIVALENTS, end of period
|
|
$
|
683,905
|
|
$
|
5,889,554
|
|
$
|
683,905
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL
DISCLOSURES OF CASH FLOW INFORMATION
|
|
|
|
|
|
|
|
|
|
|
Cash
paid for interest
|
|
$
|
20,126
|
|
$
|
9,103
|
|
$
|
175,198
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL
SCHEDULE OF NON-CASH INVESTING AND FINANCING
ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
Equipment
acquired under capital lease
|
|
$
|
109,875
|
|
$
|
72,644
|
|
$
|
410,689
|
|
Preferred
stock issued upon conversion of convertible notes
|
|
$
|
-
|
|
$
|
-
|
|
$
|
2,000,000
|
|
Reduction
in note payable to related party
|
|
$
|
-
|
|
$
|
-
|
|
$
|
150,000
|
|
Issuance
of equity in connection with issuance of convertible notes
|
|
$
|
-
|
|
$
|
-
|
|
$
|
103,403
|
|
Dividend
- roundup of odd-lot shareholders
|
|
$
|
-
|
|
$
|
-
|
|
$
|
148,811
|
|
See
accompanying notes to the condensed financial statements
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
NOTE
1 -
|
DESCRIPTION
OF THE COMPANY
|
The
business of HydroGen Corporation (the “Company”) commenced under the entity
HydroGen, L.L.C. in November 2001 to conduct the business of designing and
manufacturing air-cooled Phosphoric Acid Fuel Cell (“PAFC”) power generation
systems. On July 7, 2005, HydroGen, L.L.C. became a wholly-owned
subsidiary of Chiste Corporation, which was subsequently renamed “HydroGen
Corporation” on August 18, 2005.
The
Company is a manufacturer of multi-megawatt fuel cell systems utilizing
proprietary 400-kilowatt (kW) phosphoric acid fuel cell (PAFC) technology.
The
technology was developed by Westinghouse Electric Corporation, and was acquired
in 1993 by Fuel Cell Corporation of America (“FCA”), the Company’s predecessor.
In 2001, FCA assigned all of its ownership rights to the technology to the
Company.
NOTE
2 -
|
BASIS
OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
|
Principles
of Consolidation
The
accompanying condensed interim financial statements of the Company are
unaudited, but in the opinion of management reflect all adjustments (consisting
only of normal recurring adjustments) necessary for a fair presentation of
results for such periods. The results of operations for any interim period
are
not necessarily indicative of results for the full year. The balance sheet
at
December 31, 2007 has been derived from the audited financial statements at
that date but does not include all of the information and footnotes required
by
accounting principles generally accepted in the United States of America
for
complete financial statements. The financial statements should be read in
conjunction with the financial statements and notes thereto included in the
Company’s Annual Report on Form 10-KSB for the fiscal year ended
December 31, 2007.
The
consolidated financial statements include the accounts of the Company and
its
wholly-owned subsidiary, HydroGen LLC. All significant intercompany balances
have been eliminated in consolidation.
Revenue
Recognition
Grant
revenue is recognized as the Company incurs reimbursable costs or achieves
designated milestones as set forth under its contracts. All of the Company’s
revenue for the three and six months ended June 30, 2008 and June 30,
2007 is from grant agreements with government agencies of the State of Ohio
or
the Commonwealth of Pennsylvania.
The
Company recognizes revenue in accordance with SEC Staff Accounting Bulletin
No. 104, “Revenue Recognition” (SAB 104). Revenue is recognized when
persuasive evidence of a sale exists, the product has been delivered, the
rights
and risks of ownership have passed to the customer, the price is fixed and
determinable, and collection of the resulting receivable is reasonably assured.
For arrangements which include customer acceptance provisions, revenue is
not
recognized until the terms of acceptance are met. Reserves for sales returns
and
allowances will be estimated and provided for at the time of shipment.
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
NOTE
2 -
|
BASIS
OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
-
Continued
|
Research
and Development Expenses
Research
and development expenditures are charged to operations as incurred.
Loss
Per Share
Loss
per
common share is computed by dividing the net loss by the weighted-average
number
of common shares outstanding during the period. Shares to be issued upon
the
exercise of options and warrants aggregating 3,780,231 and 1,097,985,
respectively, as of June 30, 2008 and June 30, 2007, respectively are
not included in the computation of loss per share as their effect is
antidilutive.
Impact
of Recently Issued Accounting Standards
SFAS
No. 157, “Fair Value Measurements”
.
In
September 2006, the Financial Accounting Standards Board (“FASB”) issued
Statement of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value
Measurements” (“SFAS 157”), which establishes a framework for reporting fair
value and expands disclosures about fair value measurements. The FASB issued
FASB Staff Position (FSP) No. FAS 157-a,
Application
of FASB Statement No. 157 to FASB Statement No. 13 and Its Related Interpretive
Accounting Pronouncements That Address Leasing Transactions
,
which
eliminated lease accounting from the scope of this standard. SFAS 157, as
issued, is effective for fiscal years beginning after November 15, 2007.
The
FASB issued FASB Staff Position (FSP) No. FAS 157-b,
Effective
Date of FASB Statement No. 157
,
which
delays the effective date by one year for all nonfinancial assets and
nonfinancial liabilities, except those that are recognized or disclosed at
fair
value in the financial statements on a recurring basis, at least annually.
The
Company adopted SFAS 157 on January 1, 2008. The impact of this new
standard did not have a material impact on its financial statements.
SFAS
No. 159, “The Fair Value Option for Financial Assets and Financial
Liabilities”.
In
February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for
Financial Assets and Financial Liabilities” (“SFAS 159”). SFAS 159
provides the option to report certain financial assets and liabilities at
fair
value, with the intent to mitigate volatility in financial reporting that
can
occur when related assets and liabilities are recorded on different
bases. SFAS 159 also amends SFAS No. 115, “
Accounting
for Certain Investments in Debt and Equity Securities
,”
by
providing the option to record unrealized gains and losses on held-for-sale
and
held-to-maturity securities currently. The Company adopted SFAS 159 on
January 1, 2008. The impact of this new standard did not have a material
impact on its financial statements.
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
NOTE
2 -
|
BASIS
OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
-
Continued
|
SFAS
No. 161, “Disclosures about Derivative Instruments and Hedging
Activities”.
In March
2008, The FASB issued SFAS No. 161, “Disclosures about Derivative
Instruments and Hedging Activities” (“SFAS 161”). SFAS 161 is intended to
improve financial reporting of derivative instruments and hedging activities
by
requiring enhanced disclosures to enable investors to better understand their
effects on an entity’s financial position, financial performance, and cash
flows. SFAS 161 is effective for the Company beginning January 1, 2009. The
Company is evaluating the impact of this new standard but currently does
not
anticipate a material impact on its financial statements as a result of the
implementation of SFAS 161.
SFAS
No. 162, “The Hierarchy of Generally Accepted Accounting
Principles”.
In
May 2008, the FASB issued SFAS No. 162, “The Hierarchy of Generally
Accepted Accounting Principles” (“SFAS 162”). SFAS 162 is intended to improve
financial reporting by identifying a consistent framework, or hierarchy,
for
selecting accounting principles to be used in preparing financial statements
that are presented in conformity with generally accepted accounting principles
in the United States for non-governmental entities. SFAS 162 is effective
60
days following approval by the SEC of the Public Company Accounting Oversight
Board’s amendments to AU Section 411, “The Meaning of Present Fairly in
Conformity with Generally Accepted Accounting Principles.” The Company does not
expect SFAS 162 to have a material impact on the preparation of its financial
statements.
Use
of Estimates
The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to
make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date
of
the financial statements and the reported amounts of revenue and expenses
during
the reporting period. Actual results may differ from those
estimates.
Reclassifications
Certain
reclassifications have been made to the 2007 Financial Statements to conform
to
the 2008 presentation.
Income
Taxes
On
January 1, 2007, the Company adopted the provisions of FIN 48,
“Accounting for Uncertain Tax Positions - an Interpretation of FASB
No. 109.” The Company has determined that it does not have any uncertain
tax positions as of June 30, 2008 and 2007. The Company will record
interest and penalties associated with unrecognized tax benefits as income
tax
expense/benefit.
NOTE
3 -
|
LIQUIDITY
AND FUTURE OPERATIONS
|
The
Company’s consolidated financial statements for the quarter ended June 30,
2008 have been prepared on a going concern basis, which contemplates the
realization of assets and the settlement of liabilities and commitments in
the
normal course of business. The Company has sustained losses and has not
achieved profitability for any fiscal quarter or year. In addition, the Company
incurred a net loss of $4.0 million and $9.2 million for
the three month and six month periods ended June 30, 2008,
respectively, and has an accumulated deficit as of June 30, 2008 of
$40.7 million. The Company also anticipates that it will
incur losses in the future, due to the investment in research and development
and product and technology testing, validation and commercialization of the
Company’s technologies.
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
The
Company is in the development stage. Its current business plans include
expenditures to continue the development of the current manufacturing production
capability and to expand development efforts for next generation production
processes. These activities require the Company to add employees, purchase
production equipment, build-out additional manufacturing facilities, manufacture
400kW modules, and construct and operate test facilities. The Company does
not
believe that it can achieve profitability until it has completed its market
entry and cost reduction stages. In order to fund the costs associated with
these stages, the Company will require additional financing. Without additional
financing, the Company would need to delay certain of these activities.
On
May 28, 2008, the Company implemented a reduction-in-force resulting in the
termination of 61 full-time employees, as well as part-time staff and
independent contractors in order to conserve cash for operations. The
Company is currently seeking short-term financing. If the Company is
successful in obtaining short-term financing, the Company plans to
seek long-term financing that may include (1) obtaining private
equity funding, (2) obtaining debt financing or, (3) the sale of 50%
or more of the Company. Neither short-term nor long-term financing may be
available to the Company on terms that are acceptable to it, if at all, and
any
new financing may be dilutive to its shareholders.
As
of
August 11, 2008, the Company had approximately $347,000 of cash on-hand and
no significant accounts receivable. If the Company is unable to raise sufficient
capital, liquidity problems will cause the Company to discontinue
operations, liquidate assets, seek additional capital on less favorable terms
and/or pursue other such actions that could adversely affect future operations.
These factors raise substantial doubt as to the Company’s ability to continue
operations as a going concern. These financial statements do not include
any
adjustments relating to the recoverability and classification of assets or
the
amounts and classification of liabilities that might be necessary should
the
Company be unable to continue as a going concern.
NOTE
4 -
|
SHARE-BASED
COMPENSATION
|
The
Company has granted stock options under its 2005 Performance Equity Plan,
as
amended, (“2005 Plan”) and under its 2007 Performance Equity Plan (“2007 Plan”
and, together with the 2005 Plan, the “Plans”.) Prior to the adoption of the
2005 Plan, HydroGen, L.L.C.’s members voted to issue options for membership
units to key employees and advisors. Upon HydroGen, LLC becoming a wholly-owned
subsidiary of Chiste (the prior name of the Company), these options became
options to purchase 342,345 shares of common stock of Chiste. These options
today represent options to purchase 342,345 shares of common stock of the
Company.
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
NOTE
4 -
|
SHARE-BASED
COMPENSATION
-
Continued
|
Subject
to the provisions of the Plans, awards may be granted to employees, officers,
directors, advisors, and consultants who are deemed to have rendered or are
able
to render significant services to the Company or its subsidiaries, and who
are
deemed to have contributed or to have the potential to contribute to the
Company’s success. Incentive stock options may only be awarded to individuals
who are employees at the time of the grant. The amount of shares that may
be
issued or reserved for awards to participants under the 2005 Plan and the
2007
Plan, which was approved by shareholders at the Company’s Annual Meeting on June
22, 2007, and the amount of options issued and outstanding to purchase shares
as
of June 30, 2008 are listed in the table below.
|
Authorized
for Issuance
|
Issued
and Outstanding
|
2005
Plan
|
1,100,000
|
955,517
|
2007
Plan
|
1,300,000
|
1,064,744
|
Total:
|
2,400,000
|
2,020,261
|
Effective
January 1, 2006, the Company adopted the fair value recognition provisions
of
SFAS 123(R) using the modified prospective transition method. The adoption
of
SFAS 123 (R) resulted in share-based compensation expense of $285,029 and
$155,679 for the 3 months ended June 30, 2008 and 2007, respectively, and
$644,666 and $275,732 for the six months ended June 30, 2008 and
June 30, 2007, respectively. These expenses increased basic and diluted
loss per share by $0.02 and $0.01 for the three months ended June 30, 2008
and June 30, 2007, respectively, and by $0.05 and $0.02 for the six months
ended June 30, 2008 and June 30, 2007, respectively.
The
fair
value of each option award is estimated on the date of grant using the
Black-Scholes option valuation model that uses the assumptions noted in the
following table. As the Company’s common stock has only traded publicly since
July 8, 2005, expected volatility has been estimated according to the following
methods to allow for an adequate trading history for the Company’s common stock
to be developed for use in this estimation:
|
1)
|
Prior
to July 8, 2005
:
As the Company’s shares were not publically traded, 0% volatility was used
in accordance with SFAS 123 for options issued to employees and
consultants prior to becoming a public
company.
|
|
2)
|
July
8, 2005 - September 30, 2007
:
Expected volatility was based on an arithmetic average of the volatility
of 5 publicly-traded companies that operate in the Company’s industry or
sell into similar markets. To calculate the estimated life for
grants of
“plain vanilla” stock options, the Company used a formula proscribed by
the Securities and Exchange Commission’s Staff Accounting Bulletin No.
107.
|
|
3)
|
October
1, 2007 and thereafter
:
Using the trading history of the Company’s common stock beginning with
July 1, 2006. Management believes that this time period adequately
captures a representative history and will continue to use July
1, 2006 as
the beginning date of the measurement period until the Company
fully
develops a five year trading history from that
date.
|
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
NOTE
4 -
SHARE-BASED
COMPENSATION - Continued
Because
the Company’s employee stock options have characteristics significantly
different from those of traded options and because changes in the subjective
input assumptions can materially affect the fair value estimate, in management’s
opinion, the existing models do not necessarily provide a reliable single
measure of the fair value of its options.
The
following table summarizes the assumptions used for options granted during
the
three and six months ended June 30, 2008 and June 30,
2007.
|
Three
Months Ended
June
30, 2008
|
|
Three
Months Ended
June
30, 2007
|
|
Six
Months
Ended
June
30, 2008
|
|
Six
Months
Ended
June
30, 2007
|
Expected
life (in years)
|
6.0
|
|
2.5
- 3.5
|
|
6.0
|
|
2.5
- 3.5
|
Risk-free
interest rate
|
3.34%
|
|
4.68%
|
|
2.46%-3.34%
|
|
4.68%
|
Volatility
|
118%
|
|
66%
|
|
74%-118%
|
|
66%
|
Dividend
yield
|
--
|
|
--
|
|
--
|
|
--
|
As
of
June 30, 2008, there was $1,911,790 of total unrecognized compensation cost
related to non-vested stock options which is expected to be recognized over
a
remaining weighted average life of 8.74 years. The amount of compensation
to be
recorded in the future could be materially impacted due to the Company
’
s reduction
in
force in May 2008 and the forfeiture of unvested stock options.
There
were 57,000 and 53,500 shares of stock options granted during the six month
periods ended June 30, 2008 and June 30, 2007, respectively with a weighted
average grant-date fair value of $1.28 and $4.55, respectively.
NOTE
5 -
STATE
GRANTS
State
of Ohio Development Grant
On
August
26, 2005, the State of Ohio Department of Development provided to HydroGen
Corporation $1,250,000 as a development grant for a three phase program to
deploy, demonstrate, and commercialize the Company’s 400 kW phosphoric acid
fuel cell system. The grant is under an Ohio Fuel Cell Initiative Demonstration
Program, and is to be used towards the costs associated with the commercial
demonstration and validation of the Company’s air-cooled phosphoric acid fuel
cell module technology and for the procurement and preparation of the plant
equipment, system engineering, plant construction, and initial operations.
The
grant was given on the understanding that the Company will establish its
corporate headquarters in Ohio, locate manufacturing facilities to Ohio by
the
end of 2008, and create new full-time jobs at both the skilled and unskilled
level in Ohio. The establishment of a corporate headquarters in Ohio was
achieved in 2006. The development work which commenced in 2005 is expected
to
continue through the end of 2008. The grant was also contingent on the Company
raising its own capital, which was achieved in July 2005.
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
NOTE
5 -
STATE
GRANTS - Continued
The
grant
of the funds is on a reimbursement basis, provided the Company meets the
objectives of the grant and is carrying out the terms of the defined project
as
represented to the state. The grant reimbursement period ran from
September 1, 2005 to July 31, 2007. The grant is a deployment of
federal development funds and as such, the Company will be required to adhere
to
various federal regulations on their use and accountability for
deployment.
The
grant
may be terminated if the State of Ohio determines that the Company is not
in
compliance with certain federal regulations governing the grant or federal
employment laws, the requirements of any other applicable program statute
or
rule or with the terms of the grant agreement after suitable notice and the
passage of cure periods. Performance under the agreement is subject to a
force
majeure limitation. If there is a termination, the Company may not continue
to
incur expenses under the grant. It may be directed by the State of Ohio to
dispose of various property, data, studies, and reports, and the Company
may be
liable for damages to the State of Ohio. The Company may also request a
termination of the grant if it is unable or unwilling to comply with the
conditions of the grant.
As
of
December 31, 2007, the Company has submitted requests and has been
reimbursed for the entire grant award totaling $1,250,000.
State
of Ohio Third Frontier Fuel Cell Program
On
March 7, 2006, the Company was notified that it would be awarded $1,000,000
(the “Grant”) by the State of Ohio Third Frontier Fuel Cell Program (TFFCP) to
support the Company’s advanced manufacturing development program. On June
8, 2006, the Company entered into a Grant Agreement with the State of Ohio
pursuant to which the Grant funds are to be awarded. Under the terms of the
Grant Agreement, the Company may recoup from the State the full $1,000,000
as
Grant activities take place, and as the costs are incurred and reported.
The
Company has pledged a total of $555,000 in cost share for the program. The
Company will use the funds to dedicate appropriate personnel, consultants,
and
infrastructure to optimize decisions and resource allocations for its planned
advanced manufacturing and assembly facility to be located in Ohio. The proposed
facility will be where the Company will mass produce its standard 400 kilowatt
(kW) air-cooled PAFC modules, which will serve as the building block of its
core
product, a 2-2.5 megawatt (MW) power island. Initial production capacity
will be 25 MW per year of the Company’s 400 kW modules, and is
expected to be subsequently expanded to 100 MW per year capacity.
All
disbursements from the Grant are on a reimbursement basis, after documentation
has been provided evidencing that expenses were incurred in furtherance of
the
Grant. The term of the Grant Agreement, including reimbursement period,
has been extended to and including October 15, 2008.
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
NOTE
5 -
STATE
GRANTS - Continued
The
Grant
may be terminated if the State of Ohio determines that the Company is not
in
compliance with the applicable program rules, State of Ohio law, or with
the
terms of the Grant Agreement, after suitable notice and the passage of cure
periods. Performance by the State is also subject to the availability of
funds.
If there is a termination, the Company may not continue to incur expenses
under
the Grant, and it may be directed by the State of Ohio to dispose of various
property, data, studies and reports. The Company may further be liable for
damages to the State of Ohio in the event of default. The Company may also
request a termination of the Grant if it is unable or unwilling to comply
with
the conditions of the Grant.
Work
under the Grant commenced in June of 2006. The Company submitted requests
for
payment under this grant totaling approximately $800,302 through June 30,
2008, all of which has been collected as of that date.
On
March 27, 2008, the Company was notified that it was awarded a grant in the
amount of $525,140 by TFFCP to support Improved Fuel Cell Power Plant Efficiency
Using Cogeneration. The Company is in the process of establishing the terms
and
conditions of the Grant Agreement with TFFCP.
Pennsylvania
Energy Development Authority Grant - Fuel Cell Test
Facility
On
May
16, 2007, the Company was notified that it was awarded a grant in the amount
of
$250,000 by the Pennsylvania Energy Development Authority (PEDA) to support
the
construction of a small scale, air-cooled phosphoric acid fuel cell test
facility. The project period, as outlined within the grant agreement, is
from
October 5, 2006 through October 4, 2008. All reimbursements for the project
must
be submitted during the project period.
All
disbursements from the grant are on a reimbursement basis. Reimbursement
is made
after documentation has been provided evidencing that expenses were incurred
in
furtherance of the grant. The grant may be terminated in whole, or in part,
at
any time if PEDA determines that the terms and conditions of the Agreement
have
not been met.
The
Company has submitted requests for payment under this grant totaling
approximately $250,000, of which $225,000 has been collected through
June 30, 2008.
Pennsylvania
Energy Development Authority Grant - Clean-Up of Coke Oven
Gas
On
October 17, 2007, the Company was notified that it was awarded a grant in
the
amount of $500,000 by PEDA to support clean-up of coke oven gas for fuel
cell
operations. The Company is in the process of establishing the terms and
conditions of the Grant Agreement with PEDA.
HYDROGEN
CORPORATION AND SUBSIDIARY
(A
Development Stage Company)
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June
30, 2008
(Unaudited)
NOTE
5 -
STATE
GRANTS - Continued
Pennsylvania
NanoMaterials Commercialization Center Grant
On
October 12, 2007, the Company entered into a grant agreement (the “Grant
Agreement”) with the Pennsylvania NanoMaterials Commercialization Center (PNCC)
pursuant to which the PNCC will grant the Company approximately $230,000
to
support the development of advanced fuel cell catalyst systems. Under the
terms
of the Grant Agreement, the Company will be reimbursed by the PNCC as grant
activities take place and as the costs are incurred and reported. The Company
has pledged a total of $131,545 in cost share for this program. The Company
will
be working in cooperation with the University of Pittsburgh’s Peterson Institute
of Nano Science and Engineering on this project. The grant may be terminated
in
whole, or in part, at any time if PNCC determines that the terms and conditions
of the Grant Agreement have not been met.
The
Company has submitted requests for payment under this grant totaling
approximately $173,000, of which all has been collected through June 30,
2008.
NOTE
6 -
SUBSEQUENT
EVENTS
On
August
8, 2008, the Company received approximately $348,000 from the sale of
approximately 232 ounces, net, of platinum metal. The Company is using the
proceeds of the platinum sale for general corporate purposes.
Item
2.
|
Management's
Discussion and Analysis
|
The
following discussion and analysis provides information that we believe is
relevant to an assessment and understanding of our results of operation and
financial condition. You should read this analysis in conjunction with our
financial statements and related footnotes. This discussion and analysis
contains forward-looking statements relating to future events and our future
financial performance. These statements involve known and unknown risks,
uncertainties and other factors, including those set forth in the Annual
Report
on Form 10-KSB for the period ended December 31, 2007, which may cause our
actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance or
achievements expressed or implied by these forward-looking statements.
General
Financial
Condition of the Company
As
of
August 11, 2008, we had approximately $347,000 of cash and cash equivalents
and
no significant accounts receivable. At June 30, 2008, we had approximately
$684,000
of
cash
and cash equivalents as compared to $8.1 million of cash and cash equivalents
at
December 31, 2007. This reduction in cash and cash equivalents is
primarily due to the approximately $6.8 million of net cash used in operating
activities which was used to fund the Company’s net loss of approximately $9.2
million for the same six months ended June 30, 2008.
If
we are
unable to raise sufficient capital, liquidity problems will cause us to
discontinue operations, liquidate assets, seek additional capital on less
favorable terms and/or pursue other such actions that could adversely affect
future operations. These factors raise substantial doubt as to our ability
to
continue operations as a going concern. These financial statements do not
include any adjustments relating to the recoverability and classification
of
assets or the amounts and classification of liabilities that might be necessary
should we be unable to continue as a going concern.
We
are in
late-stage negotiations with several parties to obtain short-term financing
to
allow us to (1) complete an equity transaction or sale of the Company that
will
provide sufficient long-term financing to execute our business plan and (2)
continue our test and commercial demonstration activities at ASHTA Chemicals,
Inc. to support such transaction or sale. There is no assurance that we will
be
able to successfully complete this financing or that we will be able to do
so on
favorable terms. If we are unable to obtain timely this financing, we will
be
forced to discontinue operations and liquidate the assets of the Company.
Should we be able to secure short-term financing, there is no assurance that
we
will successfully complete an equity transaction or sale of the Company that
will provide sufficient long-term financing that will enable us to execute
our
plan of operation, complete the commercialization of our technology or achieve
cash flow positive operations.
Overview
We
have
been unable thus far this year to raise the additional funds required to
execute
our plan of operation as previously described in our Quarterly Report on
Form
10-QSB for the period ended March 31, 2008, and have therefore been forced
to
reduce our workforce by approximately 64% and curtail operations. As a result,
we will not be able to execute our plan of operation as previously described.
HydroGen’s
plan of operation still calls for us to design, manufacture and sell
multi-megawatt turn-key power plants, based on a series of standardized product
designs incorporating HydroGen’s 400 kilowatt (“kW”) fuel cell modules, and to
sell fuel cell stacks and modules to other system integrators and turn-key
project developers. Additionally, HydroGen intends to generate recurring
revenues from the sale of fuel cell stack and module operations and maintenance
(“O&M”) services.
The
principal objective of our plan of operation remains to achieve levels of
market
penetration and product cost that will enable the Company to sell profitably
phosphoric acid fuel cell (“PAFC”) stacks and modules, complete PAFC power
plants, and related O&M services. The Company believes that it can
ultimately reduce the cost of its 400kW fuel cell modules to a level that
is
comparable to the installed cost of conventional power generation in the
2 to 30
megawatt (“MW”) size class, with a product that is considerably higher in
electrical efficiency than incumbent technologies. Our targeted costs also
compare favorably to those of competitors in the stationary fuel cell arena.
HydroGen
is in the development stage and is expected to remain so until it completes
its
cost reduction and advanced manufacturing development programs as described
below.
Plan
of Operation
Our
“first article” product costs for fuel cell stacks and modules are approximately
$3,300/kW, and “first article” costs for a complete, installed PAFC power plant
are approximately $6,000/kW (both exclusive of the cost of platinum, of which
HydroGen retains ownership and recovers the majority at the end of the fuel
cell’s useful life). Management’s objective is to bring fuel cell stack and
module costs to a level of approximately $1,500/kW or less, which management
believes is a cost level necessary to achieve positive cash flow. The Company
believes that its complete PAFC systems can be sold to end users for price
levels ranging from approximately $2,000 to $5,000/kW installed, depending
on
project-specific conditions, and that PAFC stacks and modules can be provided
to
system integrators for a price of approximately $1,250 to $3,000/kW.
Because
of the Company’s inability to obtain the financing needed to support the planned
near-term multi-megawatt sales milestones described in our Quarterly Report
on
Form 10-QSB for the period ended March 31, 2008, a less capital intensive
path
has been developed. The Company remains committed to executing timely its
programs to improve product design, performance, manufacturability, and cost
to
levels required for full commercialization. However, the Company now intends
to
limit market penetration activities in the near term in order to avoid the
significant capital outlays required to subsidize sales at price points that
are
lower than our current cost to produce. Our preliminary revised plan now
targets
one multi-module power plant (intended to be of two-400kW modules) in 2009
as an
interim stepping stone leading to our first multi-megawatt sales in
2010.
Assuming
the Company obtains long-term financing to continue operations, management
intends to execute the following plan of operation in order to achieve the
necessary cost reductions and manufacturing capacities to support the Company’s
transition to profitable operation, while minimizing overall capital needs.
The
key elements of HydroGen’s plan of operation include:
1.
Demonstration
and validation of HydroGen’s PAFC technology at one or more prototypical field
sites;
2.
Initial
“turnkey” sales of complete PAFC power plants to support initial market
penetration, strategic partner training/positioning, and field operational
learning;
3.
Limited
manufacturing of fuel cell modules in our Versailles, PA manufacturing facility
to support initial sales;
4.
Next-generation
PAFC product and high volume advanced manufacturing development to deliver
necessary cost reductions; and
5.
Transition
to role of supplier / servicer of PAFC stacks and modules through partnerships
with system integrators and distributors; execution of additional strategic
agreements with system integrators and distributors.
As
discussed above, the Company will need to raise additional funds by the end
of the year to be in a position to begin to execute our plan of operation,
and
to prevent a permanent cessation of operations.
Demonstration
and Validation of HydroGen’s PAFC Technology at Customer Field Sites
The
principal purposes of HydroGen’s demonstration activities are to obtain
successful performance validation and performance history for the core
400 kW module and, in certain markets, demonstrate the Company’s ability to
process hydrogen-rich waste gas streams to specifications required for fuel
cell
operation. With successful performance validation, we anticipate that the
Company will be able to obtain initial commercial orders for full-scale PAFC
power plants consistent with HydroGen’s sales objectives as described
below. And, as we establish performance history, we believe that full
market penetration will be achieved.
On
October 17, 2006, HydroGen announced that it had signed an agreement with
ASHTA
Chemicals to install and operate a 400kW fuel cell demonstration power plant
at
ASHTA Chemical’s chlor-alkali manufacturing plant in Ashtabula, Ohio. This
effort has been partially funded by a $1,250,000 award that the Company received
from the State of Ohio Department of Development. The Company completed
construction and check-out of the demonstration power plant in 2007, in
preparation for delivery of the Company’s first newly-produced 400kW PAFC
module. The Company delivered the PAFC module on February 22, 2008 and on
April 28, 2008 successfully started up the power plant. The Company
successfully demonstrated full power operation of the fuel cell power plant
in
May 2008, and the plant was observed by potential partners and customers
during
the second quarter of 2008. Based on the achievement of full power operation
in
May 2008, we have validated our ability to manufacture fuel cells consistent
with our performance expectations.
Subsequently,
the plant was operated outside of certain pressure and temperature
specifications which are necessary to ensure proper electrolyte management.
This
required that we suspend plant operations and implement improvements in
operating procedures and overhaul the fuel cell module. During the shutdown,
management also took the opportunity to upgrade the fuel cell stacks with
second
generation electrodes that are expected to provide improved lifetime
performance, and which are necessary to establish performance history. We
also
have made additional balance of plant improvements that had been identified
and
developed during the initial plant testing. The plant is currently engaged
in
startup preparations.
Our
agreement with ASHTA Chemicals requires that we decommission the demonstration
facility by January 5, 2009. We are currently negotiating with ASHTA Chemicals
for an extension of the agreement. If we are unable to obtain such an extension,
our ability to obtain additional performance history for our 400 kW module
may
be significantly impaired, in which case the Company plans to seek a similar
arrangement with another facility or to sell a two module plant that would
provide improved demonstration capabilities.
On
March
27, 2008 the Company announced that it had received a grant of $525,140 for
Improved Fuel Cell Power Plant Efficiency Using Cogeneration. The funds were
awarded through the TFFCP in the category of Market Readiness Demonstration
Projects. The Company intends to use funds from this award at our demonstration
facility to demonstrate increased system electrical efficiency through the
addition of an organic rankine cycle heat recovery unit that will provide
additional electric power generation.
In
the
Fall of 2006, HydroGen also initiated a project to design and build a pilot
scale system to clean coke oven gas to meet the input feed requirements of
the
HydroGen PAFC system. The overall goal of this project is to support market
penetration efforts into the coke oven gas market for HydroGen’s PAFC systems.
The principal project objective is to build and demonstrate a complete prototype
coke oven gas cleanup system that will perform acceptably in a commercial
scale
plant The project is being undertaken at the United States Steel Clairton
Works
coke oven facility, the largest such facility in the United States, located
near
the Company’s manufacturing plant in Versailles, Pennsylvania. The Company has
designed and, in concert with United States Steel, has completed construction
of
the pilot scale gas treatment facility. The plant has been started up and
all
pre-commissioning checkouts satisfactorily completed, and by April 18, 2008
the plant had been optimized to produce hydrogen of sufficient purity to
meet
the gas composition requirements for operation of a HydroGen fuel cell power
plant. The plant has also completed a 5-week reliability run that has
demonstrated system robustness under commercial operating conditions. The
data
generated by the test plant will directly support power plant design and
sales
efforts into the coke oven gas market segment.
On
October 17, 2007, the Company was notified that it was awarded a grant in
the
amount of $500,000 by PEDA to support a commercial-scale system to clean
up coke
oven gas for fuel cell operations. The Company is in the process of establishing
the terms and conditions of the Grant Agreement with PEDA, which would provide
funding sufficient to cover most of the costs of a commercial scale gas
treatment system to support a multi-module fuel cell power plant at a coke
oven
works.
Initial
“turnkey” sales of complete PAFC power plants to support initial market
penetration, strategic partner training/positioning, and field operational
learning
The
Company’s plan of operation had previously called for us to execute sales
contracts for initial sales of approximately 10MW of turnkey projects in
2008
through early 2009. However, due to our inability to obtain timely sufficient
financing to support this plan, which required selling PAFC plants for a
price
lower than our production costs, the Company now anticipates a more limited
market penetration effort for the near-term, focused on one initial two-400
kW
module plant sale in 2009, followed by multi-megawatt sales in early 2010,
which
will be timed to incorporate the Company’s next-generation low cost product
design. It is likely that the anticipated two-module power plant will be
a
United States-based sale, and that the following multi-megawatt planned sales
will be pursuant to strategic agreements between HydroGen and Samsung
Corporation.
In
general, HydroGen intends to sell additional turn-key power plants in North
America and elsewhere in order to gain penetration into targeted markets.
HydroGen has been developing a pipeline of projects with several large
generators of by-product hydrogen and other potential customers who have
expressed interest in acquiring fuel cell power plants. HydroGen’s decision to
sell to these potential customers will be dependent on a number of factors,
including the quality/attractiveness of the market opportunities, the sales
prices that can be borne in those opportunities, and the product cost levels
achieved during this period through the Company’s cost reduction programs.
Limited
manufacturing of fuel cell modules in our Versailles, Pennsylvania manufacturing
facility to support initial sales
Prior
to
staff reductions undertaken in May 2008, HydroGen had principally completed
the
initial ramp up of its manufacturing facilities to achieve pilot production
capacity of up to 2 MW (five 400 kW modules) per annum on single shift basis,
and to recapture fuel cell module performance and operations generally
consistent with the original Westinghouse design specifications.
Assuming
the Company is successful in obtaining long-term financing, HydroGen intends
to
re-establish production at its Versailles facility and produce a sufficient
number of new fuel cell modules at its Versailles facility in 2008 and 2009
in
order to support new design test objectives and the delivery requirements
associated with the Company’s first anticipated sales.
Next-generation
PAFC product and high volume advanced manufacturing development to deliver
necessary cost reductions
The
present “first article” cost to produce the Company’s fuel cell modules is
approximately $3,300/kW, exclusive of platinum. The Company will aggressively
pursue opportunities for performance improvements and cost reductions that
can
be implemented immediately.
To
support the longer term cost reductions and performance improvements that
are
required in the Company’s plan of operations, management plans to implement an
integrated effort to develop the next generation of its PAFC product, and
to
manufacture that product at the high volumes required to support growth and
profitability. This effort has objectives of reducing the highest sources
of
cost in the manufacture of the PAFC module and balance of plant, executing
improvements to fuel cell stack and system performance, and implementing
significant increases in fuel cell manufacturing capacity through process
improvement, automation and outsourcing.
The
highest priority areas for cost reduction include graphite plates, catalyst
layers, non-repeating hardware, fuel cell module pressure vessel, specialty
backing papers, and labor costs. The Company’s objective is to complete the key
cost reduction initiatives and implement them in an advanced manufacturing
and
assembly facility that will automate the assembly of our fuel cell stacks,
with
components that are both outsourced and manufactured in-house. The Company
intends to bring its advanced manufacturing and assembly facility on line
in
2011. This facility is anticipated to have designed PAFC production capacity
of
approximately 25 MW/annum, and be capable of expansion to approximately 100
MW/annum. Actual capacity will by tied directly to sales. Depending on the
level
of manufacturing versus outsource and assembly of components, the Company
estimates that the development, equipment procurement, and ramp up for the
advanced manufacturing and assembly facility will require up to $20
million to $25 million
in
capital spending to achieve full 100MW/annum design capacity. The Company
intends to finance the facility principally through a package of state or
local
sponsored loans, grants, and similar incentives.
To
support these initiatives, the Company has initiated collaborative relationships
with certain industry and academic partners, and is pursuing additional
collaboration opportunities and strategic partnerships with a variety of
entities. In addition, the Company has received grant funding to support
these initiatives (including grants of $1,000,000 from the state of Ohio
Third
Frontier Fuel Cell Program (TFFCP) to support the development of our planned
advanced manufacturing and assembly facility, and approximately $230,000
from
the Pennsylvania Nano Materials Commercialization Center to support our advanced
electrode development work), and will continue to seek out and apply for
additional developmental funding. One of our partners in graphite plate
development, GrafTech International, Ltd, also received a grant award of
$973,154 from the TFFCP to support development of improved bipolar plates
for
PAFC systems using natural graphite technology. The Company believes that
it
will be able to continue work under its grants once it obtains short-term
financing.
HydroGen
has completed construction of an initial series of test facilities at its
Versailles, Pennsylvania manufacturing facilities, and should it obtain
long-term financing, plans to expand its testing capabilities, to support
the
testing and validation requirements associated with these cost reduction
and
process development initiatives.
Transition
to role of supplier / servicer of PAFC stacks and modules through partnerships
with system integrators and distributors
The
Company believes that the sale and servicing of fuel cell stacks and modules
to
system integrators / distributors, who have turn-key responsibility for fuel
cell plant delivery and installation at the end customer site, offers a higher
margin business opportunity than the construction and delivery of complete
turn-key fuel cell plants, and a faster path for the Company to achieve gross
margin and cash flow positive operations. The Company’s overall strategy is to
deploy and demonstrate multi-megawatt fuel cell plants on a turn-key basis
for
our earliest sales into key markets, and enter into strategic agreements
with
leading global system integrators / distributors with core capabilities in
system engineering, plant construction, and marketing which can effectively
penetrate those markets.
Agreements
between HydroGen and Samsung Corporation represent the implementation of
this
strategy for the Asian and Middle Eastern markets. The Company anticipates
selling on a turnkey basis its first two multi-megawatt PAFC plants to Samsung.
The turnkey power plants may be either hydrogen-available plants or a
combination of hydrogen-available and hydrocarbon fueled power plants. The
Company will also design a multi-megawatt power plant to be fueled by
hydrocarbon gas, after which the Company and Samsung anticipate entering
into an
Exclusive Distribution and Marketing Agreement for that market segment in
Asia
and the Middle East. The Company anticipates that subsequent sales to Samsung
will be of fuel cell stacks and modules, with Samsung having responsibility
for
turn-key plant delivery. To achieve this objective, HydroGen and Samsung
plan to
enter into a BOP Technology Transfer, Licensing, and Technical Support Agreement
pursuant to which Samsung shall obtain (in exchange for a royalty fee) certain
rights to deliver to Samsung’s customers, fuel cell power plants utilizing
HydroGen’s plant designs and related proprietary rights and confidential
information. Through this agreement, HydroGen will transition into the role
of a
supplier of fuel cell stacks and modules to Samsung, who will market,
distribute, and deliver complete PAFC plants in their territory.
The
Company will support both turn-key and fuel cell stack/module sales with
fuel
cell module Operations and Maintenance (“Module O&M”) agreements. Module
O&M services will include dedicated monitoring and trending of fuel cell
operating parameters, fuel cell plant operational support, and stack or module
replacements as necessary. The Company believes that Module O&M services may
generate high margins and significant cash flow to the business as the number
of
units in the field increases, particularly as fuel cell module lifetime,
and
fuel cell plant operating techniques, improve.
Although
the Company will target higher-margin stack and module sales to Samsung
Corporation and others for the majority of its product sales, it will also
engage in limited additional sales of turn-key PAFC systems. These turn-key
sales will support market penetration into new markets (geographic and
application), and in parallel, the consummation of agreements, similar to
those
in place with Samsung Corporation, with other system integrators/ distributors
focused on those markets. HydroGen will focus on the following markets, among
others: Domestic/North American market opportunities in chlor-alkali / sodium
chlorate; coke-oven gas market applications; opportunities in states that
offer
significant incentives for adoption of stationary fuel cell systems. The
total
number of turn-key sales targeted for the period will be set annually by
the
Company, and will be a function of the quality/attractiveness of the market
opportunities, the sales prices that can be borne in those opportunities,
and
the product cost levels achieved during this period through the Company’s cost
reduction programs.
Nasdaq
Deficiency Notice
On
July
9, 2008, we received a Nasdaq Staff Deficiency Letter indicating that the
Company has failed to comply with the minimum bid price requirement for
continued listing on the The Nasdaq Stock Market set forth in Marketplace
Rule
4310(c)(4) for thirty (30) consecutive trading days. The deficiency letter
further stated that we have until January 6, 2009 to regain compliance. If
we do
not demonstrate compliance with the rule by January 6, 2009, the staff of
NASDAQ
will determine whether we meet the Nasdaq Capital Market initial listing
criteria, except for the bid price requirement. If the staff
determines that we meet the initial listing criteria, we will be granted
an
additional 180 calendar day compliance period. Otherwise, the staff will
provide written notification that our securities will be delisted from the
Nasdaq Capital Market. In that case, prior to any delisting, we may
appeal to a Listing Qualifications Panel. Should our securities be delisted
from
the Nasdaq Captial Market our ability to secure financing in the capital
markets
would be further weakened and our stock would be more difficult to trade,
reducing its trading volume and further depressing our stock price.
Critical
Accounting Policies and Estimates
There
have been no changes to critical accounting policies and estimates from those
disclosed in our December 31, 2007 consolidated financial statements filed
on Form 10-KSB other than the implementation of SFAS 157 and SFAS 159 as
described below.
SFAS
No. 157, “Fair Value Measurements”
.
In
September 2006, the FASB issued SFAS No. 157, “Fair Value
Measurements” (“SFAS 157”), which establishes a framework for reporting fair
value and expands disclosures about fair value measurements. The FASB issued
FASB Staff Position (FSP) No. FAS 157-a,
Application
of FASB Statement No. 157 to FASB Statement No. 13 and Its Related Interpretive
Accounting Pronouncements That Address Leasing Transactions
,
which
eliminated lease accounting from the scope of this standard. SFAS 157, as
issued, is effective for fiscal years beginning after November 15, 2007.
The
FASB issued FASB Staff Position (FSP) No. FAS 157-b,
Effective
Date of FASB Statement No. 157
,
which
delays the effective date by one year for all nonfinancial assets and
nonfinancial liabilities, except those that are recognized or disclosed at
fair
value in the financial statements on a recurring basis, at least annually.
We
adopted SFAS 157 on January 1, 2008. The impact of this new standard did
not have a material impact on our financial statements.
SFAS
No. 159, “The Fair Value Option for Financial Assets and Financial
Liabilities”.
In
February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for
Financial Assets and Financial Liabilities” (“SFAS 159”). SFAS 159
provides the option to report certain financial assets and liabilities at
fair
value, with the intent to mitigate volatility in financial reporting that
can
occur when related assets and liabilities are recorded on different
bases. SFAS 159 also amends SFAS No. 115, “
Accounting
for Certain Investments in Debt and Equity Securities
,”
by
providing the option to record unrealized gains and losses on held-for-sale
and
held-to-maturity securities currently. We adopted SFAS 159 on January 1,
2008. The impact of this new standard did not have a material impact on our
financial statements.
Financing
Activities
State
of Ohio and Commonwealth of Pennsylvania Financings
On
August
26, 2005, the State of Ohio Department of Development provided to HydroGen
Corporation $1,250,000 as a development grant for a three phase program to
deploy, demonstrate, and commercialize the Company’s 400 kW phosphoric acid
fuel cell system. The grant is under an Ohio Fuel Cell Initiative Demonstration
Program, and is to be used towards the costs associated with the commercial
demonstration and validation of the Company’s air-cooled phosphoric acid fuel
cell module technology and for the procurement and preparation of the plant
equipment, system engineering, plant construction, and initial operations.
The
grant was given on the understanding that the Company will establish its
corporate headquarters in Ohio, locate manufacturing facilities to Ohio by
the
end of 2008, and create new full-time jobs at both the skilled and unskilled
level in Ohio. The establishment of a corporate headquarters in Ohio was
achieved in 2006. The development work which commenced in 2005 is expected
to
continue through the end of 2008. The grant was also contingent on the Company
raising its own capital, which was achieved in July 2005.
The
grant
of the funds is on a reimbursement basis, provided the Company meets the
objectives of the grant and is carrying out the terms of the defined project
as
represented to the state. The grant reimbursement period ran from
September 1, 2005 to July 31, 2007. The grant is a deployment of
federal development funds and as such, the Company will be required to adhere
to
various federal regulations on their use and accountability for
deployment.
The
grant
may be terminated if the State of Ohio determines that the Company is not
in
compliance with certain federal regulations governing the grant or federal
employment laws, the requirements of any other applicable program statute
or
rule or with the terms of the grant agreement after suitable notice and the
passage of cure periods. Performance under the agreement is subject to a
force
majeure limitation. If there is a termination, the Company may not continue
to
incur expenses under the grant. It may be directed by the State of Ohio to
dispose of various property, data, studies, and reports, and the Company
may be
liable for damages to the State of Ohio. The Company may also request a
termination of the grant if it is unable or unwilling to comply with the
conditions of the grant.
As
of
December 31, 2007, the Company had submitted requests and had been
reimbursed for the entire grant award totaling $1,250,000.
On
March 7, 2006, the Company was notified that it would be awarded $1,000,000
(the “Grant”) by the State of Ohio Third Frontier Fuel Cell Program (TFFCP) to
support the Company’s advanced manufacturing development program. On June
8, 2006, the Company entered into a Grant Agreement with the State of Ohio
pursuant to which the Grant funds are to be awarded. Under the terms of the
Grant Agreement, the Company may recoup from the State the full $1,000,000
as
Grant activities take place, and as the costs are incurred and reported.
The
Company has pledged a total of $555,000 in cost share for the program. The
Company will use the funds to dedicate appropriate personnel, consultants,
and
infrastructure to optimize decisions and resource allocations for its planned
advanced manufacturing and assembly facility to be located in Ohio. The proposed
facility will be where the Company will mass produce its standard 400 kilowatt
(kW) air-cooled PAFC modules, which will serve as the building block of its
core
product, a 2-2.5 megawatt (MW) power island. Initial production capacity
will be 25 MW per year of the Company’s 400 kW modules, and is
expected to be subsequently expanded to 100 MW per year capacity.
All
disbursements from the Grant are on a reimbursement basis, after documentation
has been provided evidencing that expenses were incurred in furtherance of
the
Grant. The term of the Grant Agreement, including reimbursement period,
has been extended to and including October 15, 2008. At the close of
the Grant term, the Company will own all equipment valued over $5,000 purchased
with Grant money.
The
Grant
may be terminated if the State of Ohio determines that the Company is not
in
compliance with the applicable program rules, State of Ohio law, or with
the
terms of the Grant Agreement, after suitable notice and the passage of cure
periods. Performance by the State is also subject to the availability of
funds.
If there is a termination, the Company may not continue to incur expenses
under
the Grant, and it may be directed by the State of Ohio to dispose of various
property, data, studies and reports. The Company may further be liable for
damages to the State of Ohio in the event of default. The Company may also
request a termination of the Grant if it is unable or unwilling to comply
with
the conditions of the Grant.
Work
under the Grant commenced in June of 2006. The Company submitted requests
for
payment under this grant totaling approximately $800,302 through June 30,
2008, all of which has been collected as of that date.
On
March 27, 2008, the Company was notified that it was awarded a grant in the
amount of $525,140 by the State of Ohio Third Frontier Fuel Cell Program
(TFFCP)
to support Improved Fuel Cell Power Plant Efficiency Using Cogeneration.
The
Company is in the process of establishing the terms and conditions of the
Grant
Agreement with TFFCP.
On
May
16, 2007, the Company was notified that it was awarded a grant in the amount
of
$250,000 by the Pennsylvania Energy Development Authority (PEDA) to support
the
construction of a small scale, air-cooled phosphoric acid fuel cell test
facility. The project period, as outlined within the grant agreement, is
from
October 5, 2006 through October 4, 2008. All reimbursements for the project
must
be submitted during the project period. The Company has submitted requests
for
payment under this grant totaling approximately $250,000, $225,000 of which
has
been collected through June 30, 2008.
On
October 17, 2007, the Company was notified that it was awarded a grant in
the
amount of $500,000 by the Pennsylvania Energy Development Authority (PEDA)
to
support clean-up of coke oven gas for fuel cell operations. The Company is
in
the process of establishing the terms and conditions of the Grant Agreement
with
PEDA.
On
October 12, 2007, the Company entered into a grant agreement (the “Grant
Agreement”) with the Pennsylvania NanoMaterials Commercialization Center (PNCC)
pursuant to which the PNCC will grant the Company approximately $230,000
to
support the development of advanced fuel cell catalyst systems. The Company
has
pledged a total of $131,545 in cost share for this program. The Company will
be
working in cooperation with the University of Pittsburgh’s Peterson Institute of
Nano Science and Engineering on this project. The Company has submitted requests
for payment under this grant totaling approximately $173,000, all of which
has
been collected through June 30, 2008.
Results
of Operations
Comparison
of the Three Months Ended June30, 2008 and 2007
Grant
revenue decreased by approximately $323,000 during the three months ended
June 30, 2008 compared to the three months ended June 30, 2007 due to
a decrease in the amount of funds remaining for reimbursement under our grants
and an associated decrease in related reimbursable expense.
Interest
and other income increased by approximately $196,000 during the three months
ended June 30, 2008 compared to the three months ended June 30, 2007
due to the recovery and sale of platinum from a discarded test module in
June
2008 that resulted in miscellaneous income in the amount $430,000 compared
to
$234,000 in the three months ended June 30, 2007.
The
following table sets forth certain of HydroGen’s operating data for the three
months ended June 30, 2008 and June 30, 2007:
|
|
June
30, 2008
|
|
June
30, 2007
|
|
Increase
(Decrease)
|
|
Research
& development
|
|
$
|
2,599,000
|
|
$
|
2,929,000
|
|
$
|
(330,000
|
)
|
Payroll
and related costs
|
|
|
650,000
|
|
|
674,000
|
|
|
(24,000
|
)
|
Stock
based compensation
|
|
|
285,000
|
|
|
156,000
|
|
|
129,000
|
|
Other
|
|
|
920,000
|
|
|
945,000
|
|
|
(25,000
|
)
|
Totals
|
|
$
|
4,454,000
|
|
$
|
4,704,000
|
|
$
|
(250,000
|
)
|
The
decrease in research and development costs relates to a general curtailment
of
the Company’s operations during the three months ended June 30, 2008 compared to
the three months ended June 30, 2007 due to the Company’s inability to raise
capital to support its operations. This reduction in operations included
the termination of 57 research and development personnel in late May
2008.
The
decrease in payroll and related costs relates to a general curtailment of
the
Company’s operations during the three months ended June 30, 2008 compared to the
three months ended June 30, 2007 due to the Company’s inability to raise capital
to support its operations. This reduction in operations included the
termination of approximately 8 general and administrative personnel in late
May
2008.
The
increase in stock based compensation expense during the three months ended
June 30, 2008 compared to the three months ended June 30, 2007 relates
primarily to an increased level of stock options provided to employees that
vest
and are expensed over this period, as well as an increase in stock price
volatility which impacted the value of stock options granted during the
period.
The
decrease in other expenses relates to a general curtailment of the Company’s
operations during the three months ended June 30, 2008 compared to the three
months ended June 30, 2007 due to the Company’s inability to raise capital to
support its operations.
Comparison
of the Six Months Ended June 30, 2008 and June 30, 2007
Grant
revenue decreased by approximately $440,000 during the six months ended
June 30, 2008 compared to the six months ended June 30, 2007 due to a
decrease in the amount of funds remaining for reimbursement under our grants
and
an associated decrease in related reimbursable expense.
Interest
and other income decreased by approximately $21,000 during the six months
ended
June 30, 2008 compared to the six months ended June 30, 2007 due to a
significantly decreasing cash balance. This decrease was partially offset
by the
recovery and sale of platinum from a discarded test module in June 2008 that
resulted in miscellaneous income in the amount of $422,000.
The
following table sets forth certain of HydroGen’s operating data for the six
months ended June 30, 2008 and June 30, 2007:
|
|
June
30, 2008
|
|
June
30, 2007
|
|
Increase
(Decrease)
|
|
Research
& development
|
|
$
|
6,151,000
|
|
$
|
5,219,000
|
|
$
|
932,000
|
|
Payroll
and related costs
|
|
|
1,339,000
|
|
|
1,283,000
|
|
|
56,000
|
|
Stock
based compensation
|
|
|
645,000
|
|
|
276,000
|
|
|
369,000
|
|
Other
|
|
|
1,899,000
|
|
|
1,773,000
|
|
|
126,000
|
|
Totals
|
|
$
|
10,034,000
|
|
$
|
8,551,000
|
|
$
|
1,483,000
|
|
The
increase in research and development costs was due to the continuing
acceleration and expansion of ramp-up activities, power plant design, and
other
development activities during the six months ended June 30, 2008 compared
to the
six months ended June 30, 2007. The number of employees hired by the Company
to
contribute to the research and development effort increased by 28, and resulted
in increased labor and fringe benefit costs of approximately $270,000 prior
to
the curtailment of the Company’s operations in late May, 2008, when 57 employees
were terminated. The purchase of consulting services, primarily related to
the
Company’s fuel cell demonstration plant, increased by approximately $800,000.
The purchase of module materials increased by approximately $900,000 due
to the
preparation for delivery of the Company’s first newly-produced 400kW PAFC
module
.
Further,
the purchases of non-capitalized equipment and materials consumed within
the
Company’s manufacturing process decreased by approximately $1,000,000 due to the
completed construction and check-out of the 400kW fuel cell demonstration
power
plant at ASHTA’s chlor-alkali manufacturing plant in Ashtabula,
Ohio.
The
increase in payroll and related costs reflect an expansion of HydroGen’s
administrative staff to support the acceleration and expansion of activities.
The number of employees hired by the Company to support increased activity
since
June 30, 2007 has been approximately 3, and has resulted in increased labor
and
fringe benefit costs of approximately $70,000.
The
increase in stock based compensation expense during the six months ended
June 30, 2008 compared to the six months ended June 30, 2007 relates
primarily to an increased level of stock options provided to employees that
vest
and are expensed over this period, as well as an increase in stock price
volatility which impacted the value of stock options granted during the
period.
The
increase in other expenses related to several factors. Depreciation expense
increased by approximately $100,000 due to new manufacturing assets placed
in
service. Insurance expense increased by $65,000 due to increased general
liability coverage. These increases were partially offset by a decrease of
approximately $95,000 in computer related purchases and $22,000 in travel
and
entertainment expense.
Liquidity
and Capital Resources
At
June 30, 2008, our cash and cash equivalents totaled $684,000. On
May 28, 2008, the Company implemented a reduction-in-force resulting in the
termination of 61 full-time employees, as well as part-time staff and
independent contractors in order to conserve cash for
operations.
As
of
August 11, 2008, the Company had approximately $347,000 of cash on-hand and
no significant accounts receivable. The Company is currently seeking short-term
financing. If the Company is sucessful in obtaining short-term financing,
the
Company plans to seek long-term financing that may
include: (1) obtaining private equity funding, (2) obtaining debt
financing, or (3) the sale of 50% or more of the Company. Neither
short-term nor long-term financing may be available to the Company on terms
that
are acceptable to it, if at all, and any new financing may be dilutive to
its
shareholders. If the Company is unable to raise sufficient capital,
liquidity problems will cause the Company to discontinue operations,
liquidate assets, seek additional capital on less favorable terms and/or
pursue
other such actions that could adversely affect future operations. These factors
raise substantial doubt as to the Company’s ability to continue operations as a
going concern.
We
have
historically financed our operations primarily from proceeds of the sale
of
equity securities and revenues or funds received under research and development
contracts and grants. We presently do not have any bank lines of credit that
provide us with an additional source of debt financing.
Item
3.
|
Quantitative
and Qualitative Disclosures About Market
Risk
|
Not
applicable to smaller reporting companies.
Item
4.
|
Controls
and Procedures
|
As
of the
end of the period covered by this report, the Company conducted an evaluation,
under the supervision and with the participation of the Chief Executive Officer
and Chief Financial Officer, of the Company’s disclosure controls and procedures
(as defined in Rules 13a-15(e) and 15d-15(e) under the 1934 Act. Based on
this
evaluation, the Chief Executive Officer and Chief Financial Officer concluded
that the Company’s disclosure controls and procedures are effective to ensure
that information required to be disclosed by the Company in reports that
it
files or submits under the 1934 Act is recorded, processed, summarized and
reported within the time periods specified in Securities and Exchange Commission
rules and forms. There was no change in the Company’s internal control over
financial reporting during the Company’s most recently completed fiscal quarter
that has materially affected, or is reasonably likely to materially affect,
the
Company’s internal control over financial reporting.
On
May 28, 2008, the Company implemented a reduction-in-force resulting in the
termination of 61 full-time employees, including the Company’s controller and
financial planning professional. The Company now has 3 employees in its
finance/accounting department, inclusive of its Chief Financial Officer.
These
employees are now performing the tasks previously performed by the terminated
financial professionals.
Because
of the impact that these terminations had on the Company’s internal controls,
notably concerning segregation of duties, the Company put in place compensating
controls to maintain the integrity of its internal controls over financial
reporting. These compensating controls include, but are not limited to,
increased controls over cash disbursements, weekly cash and expenditure
reporting to the Company’s CEO and President, and increased and more frequent
oversight over the Company’s financial position by the Company’s Board of
Directors. The Company therefore believes that its internal controls over
financial reporting are effective.
PART
II.
|
OTHER
INFORMATION
|
Item
1.
|
Legal
Proceedings
|
None.
Item
2.
|
Unregistered
Sales of Equity Securities and Use of
Proceeds
|
None.
Item
3.
|
Defaults
Upon Senior Securities
|
None.
Item
4.
|
Submission
of Matters to a Vote of Security
Holders
|
None.
Item
5.
|
Other
Information
|
None.
|
31.1
|
Certification
pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities
Exchange Act
of 1934, as amended of John J.
Freeh.
|
|
31.2
|
Certification
pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities
Exchange Act
of 1934, as amended of Joshua
Tosteson.
|
|
31.3
|
Certification
pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities
Exchange Act
of 1934, as amended of Scott
Schecter.
|
|
32
|
Certification
of the Chief Executive Officer, President and Principal Financial
Officer
of the Company, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to
Section 906 of the Sarbanes-Oxley Act of
2002.
|
SIGNATURES
In
accordance with the requirements of the Exchange Act, the registrant caused
this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
|
HYDROGEN
CORPORATION
|
|
|
|
|
By:
|
/s/ John
J.
Freeh
|
|
Chief
Executive Officer
Date:
August 19, 2008
|
|
|
|
|
|
|
|
By:
|
/s/ Joshua
Tosteson
|
|
President
Date:
August 19, 2008
|
|
|
|
|
|
|
|
By:
|
/s/ Scott
Schecter
|
|
Principal
Financial Officer
Date:
August 19, 2008
|